Ligand Pharmaceuticals (LGND) Q2 2022 Earnings

4MayConfirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
0.58
0.99
1.39
1.8

Details

Expected EPS
0.66
Actual EPS
0.58
Surprise EPS
-0.08
Surprise Percent
+12.12%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 0.58 per share for Q2 2022.

0 Comments

Share your thoughts